Built for CRO Performance. Designed for Trial Complexity.
You operate in one of the most demanding environments in healthcare. Medidata’s clinical trial platform gives CROs the control, collaboration, and clarity needed to manage complexity at scale.
Advanced capabilities are paired with dedicated partnership support to help you deliver predictable outcomes across diverse global programs.
Ready to explore how to strengthen your delivery model?
Explore Partner Resources
Partner Program
Leverage our Partner Program.
Win. Innovate. Outperform.
CRO Partner Directory
Learn about our CRO Partners who trust
Medidata to guide every step of the way.
Partner Portal
Manage bids, quotes, and contracts and access self service resources all in one place.
Why CROs Choose and Trust Medidata
Your success depends on delivering speed, quality, and predictability across increasingly complex global trials. Medidata Experiences are designed to manage complexity with confidence.
By connecting patient, data, and study workflows into one unified system, you reduce operational friction, streamline trial execution, control costs, and accelerate therapy development.
Digital capabilities are embedded directly into how trials run, helping you improve collaboration, strengthen oversight, and deliver measurable impact for sponsors and patients alike.
This isn’t just technology. It’s a platform built to help you execute better—and earn trust at scale.
Patient Experience
Simplify patient participation
Gain longitudinal engagement throughout a patient’s trial lifecycle
Break the transactional nature of patient engagement with end-to-end patient-centric solutions
Data Experience
Streamline data acquisition for quality and pace
Automate data integration and transformation
Accelerate actionable insights
Study Experience
Speed up clinical trial design, planning, and management
Make better decisions with better data
Connect workflows, data, and teams with AI and advanced analytics
9 out of the top 10 CROs with Medidata, 31 for 15+ years and 113 for 10+ years
including 2,000+ rare disease studies and 90% of oncology approvals in 2022
achieving >95% of patient compliance when using our tools
Approvals used Medidata in 2025
Why This Platform Is Fundamentally Different
Choosing the Medidata Platform:
The Common Denominator amongst Sites
Our CMO, our CEO, and I set out to ask sites what solutions they were accustomed to and what solutions they were comfortable with… The prevailing theme was they’ve used Rave EDC.
Keya Watkins
SVP, Clinical Development Operations
Having a unified platform really cuts down on the number of workflows that you normally would have to have when you're using multiple vendors. Data is flowing through the one system. You have the traceability at your hand. You're removing two or three steps. All that documentation flows - removing the redundancy from multiple systems. It allows us to be efficient, keep costs down for us and our clients.
Michael Mendoza
VP, Biometrics and Data Science
With Medidata, the support that we get as a company and the interest that Medidata has in seeing us succeed is real. It’s beyond a vendor relationship. This is a true partnership. Caidya, Medidata, we are all in this together. That support means a lot to us as a company.
Robyn Orie
Senior Director, Data Innovation
We’re getting big requests from sponsors to make sure that we’re using Medidata in a way that sees data get ingested into that platform, creating a centralized location for sites and patients to work with.
Luke Gregory
Director, Clinical Systems
From a partnership perspective, we've been really impressed with Medidata’s Professional Services team. They've really come in and supported us. They've been so welcoming and able to jump on calls with us, walk through our problems, where we're seeing some potential efficiencies and solutions, and provide that pretty instantaneously.
Heather Kresge
VP, Biometrics and Pharmacovigilance
